Evidence map›Paper›PMID 37127721›Full record

SynthesisArchives of public health = Archives belges de sante publique2023

Chikungunya seroprevalence in population-based studies: a systematic review and meta-analysis.

Lacita Menezes Skalinski, Aline Elena Sacramento Santos, Enny Paixão, Martha Itaparica, Florisneide Barreto, Maria da Conceição Nascimento Costa, Maria Glória Teixeira

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Archives of public health = Archives belges de sante publique, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Chikungunya: a decade of burden in the Americas.Lancet regional health. Americas · 2024
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lacita Menezes SkalinskiUniversidade Estadual de Santa Cruz, Rodovia Jorge Amado, km 16, s/n, Salobrinho, Ilhéus, CEP 45662-900, BA, Brasil. lmskalinski@uesc.br.
Aline Elena Sacramento SantosInstituto de Saúde Coletiva/ Universidade Federal da Bahia, Rua Basílio da Gama, s/n, Campus Canela, Salvador, CEP 40110-040, BA, Brazil.
Enny PaixãoLondon School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK.
Martha ItaparicaInstituto de Saúde Coletiva/ Universidade Federal da Bahia, Rua Basílio da Gama, s/n, Campus Canela, Salvador, CEP 40110-040, BA, Brazil.
Florisneide BarretoInstituto de Saúde Coletiva/ Universidade Federal da Bahia, Rua Basílio da Gama, s/n, Campus Canela, Salvador, CEP 40110-040, BA, Brazil.
Maria da Conceição Nascimento CostaInstituto de Saúde Coletiva/ Universidade Federal da Bahia, Rua Basílio da Gama, s/n, Campus Canela, Salvador, CEP 40110-040, BA, Brazil.
Maria Glória TeixeiraInstituto de Saúde Coletiva/ Universidade Federal da Bahia, Rua Basílio da Gama, s/n, Campus Canela, Salvador, CEP 40110-040, BA, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeroprevalence studies about chikungunya infection are usually conducted after epidemics to estimate the magnitude of the attack. This study aimed to estimate the seroprevalence of CHIKV by WHO region, considering the periods of introduction of the virus in these regions and its potential to lead to epidemics.

methodsWe systematically reviewed Medline/Pubmed, Embase, Lilacs, Scopus and Web of Science for original articles published up to 2020. Cohort, case-control and cross-sectional studies were eligible for inclusion, based on the results of laboratory diagnosis of previous or previous and recent infection. Those conducted with symptomatic individuals were excluded.

results596 articles were identified, 197 full-text were reviewed and 64 were included, resulting in 71 seroprevalences. Most were cross-sectional studies (92%), between 2001 and 2020 (92%), with population of all ages (55%), conducted in Kenya (10.9%), Brazil (9.4%) and French Polynesia (7.8%). The pooled estimates were 24% (95%CI 19-29; I

conclusionsThe great heterogeneity of seroprevalences points to the persistence of viral circulation. Even where the seroprevalence is high, the population replacement and the absence of vaccines mean that the risk of virus spread and epidemics remains. REGISTRATION: PROSPERO CRD42020166227.

Indexed as

Chikungunya VirusHealth SurveysSeroepidemiologic Studies

Identifiers

PMID37127721
PMCPMC10150504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.